Adjuvant and induction chemotherapies in non-small-cell lung cancer;Adjuvante Chemotherapie und Induktionschemotherapien beim nichtkleinzelligen Bronchialkarzinom

Onkologie

Volumn 19, Issue 3, 1996, Pages 221-225

  Pirker, R ^a,c   Zochbauer S ^a   Krajnik, G ^b   Salzer, G M ^b   Eckersberger, F ^a   Huber, H ^b  

^a Abteilung Für Onkologie   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Adjuvant chemotherapy; Induction chemotherapy; Neoadjuvant chemotherapy; Non small cell lung cancer

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT RESPIRATORY DISTRESS SYNDROME; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; LUNG NON SMALL CELL CANCER; PATIENT COMPLIANCE; REVIEW;

EID: 0029818595     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Zöchbauer S, Krajnik G, Huber H: Bronchuskarzinom: Entstehung, Diagnose, Therapie, Prognose. Wen Klin Wochenschr 1994;106:431-447.
2. Rose LJ: Neoadjuvant and adjuvant therapy of nonsmall cell lung cancer. Semin Oncol 1991;18:536-542.
3. Shepherd FA: Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg 1993;55:1585-1592.
4. Manegold C, Drings P: Zur Rolle der Chemotherapie beim nichtkleinzelligen Bronchuskarzinom im Tumorstadium III. Onkologie 1994;17:294-302.
5. Johnson DH: Chemotherapy for stage III non-small cell lung cancer. Lung Cancer 1994;11(suppl 2): 148-150.
6. Lilenbaum RC, Green MR: Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J Clin Oncol 1993;11:1391-1402.
7. Pirker R, Krajnik G, Zöchbauer S, Malayeri R, Kneussl M, Huber H: Paclitaxel/cisplatin in advanced non-small-cell lung cancer. Ann Oncol 1995;6: 833-835.
8. Donnadieu N, Paesmans M, Sculier JP: Chemotherapy of non-small cell lung cancer according to disease extent: A meta-analysis of the literature. Lung Cancer 1991;7:243-253.
9. Holmes EC: Surgical adjuvant chemotherapy in non-small cell lung cancer. Semin Oncol 1988; 15:255-260.
10. Holmes EC, Gail M for the Lung Cancer Study Group: Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 19S6;4:710-715.
11. Lung Cancer Study Group: The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. J Clin Oncol 1988;6:9-17.
12. Feld R, Rubinstein L, Thomas PA and the Lung Cancer Study Group: Adjuvant chemotherapy with cyclophosphamide, doxorubicin and cisplatin in patients with completely resected stage I non-smallcell lung cancer. J Natl Cancer Inst 1993;85:299-306.
13. Ferguson MK, Little AG, Golomb HM, Hoffman PC, DeMeester TR, Beveridge R, Skinner DB: The role of adjuvant therapy after resection of T1N1MO and T2N1MO non-small cell lung cancer. J Thorac Cardiovasc Surg 19S6;91:344-349.
14. Niiranen A, Niitamo-Korhonen S, Kouri M, Assendelft A, Mattson K, Pyrhönen S: Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study. J Clin Oncol 1992;10: 1927-1932.
15. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A metaanalysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995; 311:899-909.
16. Lung Cancer Study Group: Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N EnglJ Med 1986;315:1377-1381.
17. Cox JD, Stanley K, Petrovish Z, Paig C, Yesner R: Cranial irradiation in cancer of the lung of all cell types. JAMA 1981245:469-472.
18. Strauss GM, Langer MP, Elias AD, Skarin AT, Sugarbaker DJ: Multimodality treatment of stage IIIA non-small-cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 1992;10:S29-83S.
19. Burkes RL, Ginsberg RJ, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Cooper JD: Induction chemotherapy with mitomycin, vindesine and cisplatin for stage III unresectable non-small cell lung cancer: Results of the Toronto phase.II trial. J Clin Oncol 1992;10: 580-586.
20. Martini N, Kris MG, Flehinger BJ, Gralla RJ, Bains MS, Burt ME, Heelan R, McCormack PM, Pisters KM, Rigas JR: Preoperative chemotherapy for stage IIIA (N2) lung cancer: The Memorial Sloan-Kettering experience with 136 pa-tients. Ann Thorac Surg 1993p5:1365-1374.
21. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Menker H, Müller MR, Stahl M, Fuths U, Klaassen U, Schienger L, Harstrick A, Budach V, Nowrousian MR, Greshuchna D, Konietzko N, Seeber S: Results of a multimodality preoperative induction treatment in locally advanced NSCLC stages IIIA and IHR Eur J Cancer 199531 A(suppl 5):S222 (abstract 1065).
22. Burt ME, Pomerantz AH, Bains MS, McCormack PM, Kaiser LR, Hilaris BS, Martini N: Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am 19S7;67:945-949.
23. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J: Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis. Ann Thorac Surg 1992; 53:992-998.
24. Resell R, Gcmez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A, Canela M, Ariza A, Skacel Z, Morera-Prat J, Abad A: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N EngI J Med 1994;330:153-158.
25. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, Caro LD, Chasen M, McGavran M, Atkinson EN, Hong WK: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 1994;S6:673-680.
26. Albain KS, Rusch VW, Crowley JL, Rice TW, Turrisi AT III, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, Fosmire H, Tajior SA, Stelzer KJ, Beasley KR, Livingston RB: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 1995;13:18SO-1S92.
27. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR: A randomized trial of induction chemotherapy plus highdose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-945.
28. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, LacombeTerrier MJ, Douillard JY, Laplanche A: Radiotherapy alone versus combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients J Natl Cancer Inst 1991 ;83:417-423.
29. Schaake-Koning C, Bogaert W van den, Dalesio O, Festen J, Hoogenhout J, Houtte P van, Kirkpatrick A, Koolen M, Maat B, Nijs A: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992326:524-530.
30. Rusch VW, Benfield JR: Neoadjuvant therapy for lung cancer: A note of caution. Ann Thorac Surg 1993;35:820-821.